Marshall Wace’s Enlivex Therapeutics ENLV Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-6,386	Closed	-$39K	–	2788
2021 Q4	$39K	Buy	+6,386	New	+$39K	﹤0.01%	2903
2021 Q2	–	Sell	-33,889	Closed	-$376K	–	2208
2021 Q1	$376K	Buy	+33,889	New	+$376K	﹤0.01%	1738